Karyopharm Therapeutics Inc. Annual Depreciation in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2023.
  • Karyopharm Therapeutics Inc. Depreciation for the quarter ending March 31, 2024 was $85K, a 70.7% decline year-over-year.
  • Karyopharm Therapeutics Inc. annual Depreciation for 2023 was $530K, a 14.7% decline from 2022.
  • Karyopharm Therapeutics Inc. annual Depreciation for 2022 was $621K, a 21.3% decline from 2021.
  • Karyopharm Therapeutics Inc. annual Depreciation for 2021 was $789K, a 18.8% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $530K -$91K -14.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $621K -$168K -21.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $789K -$183K -18.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $972K -$2K -0.21% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $974K +$239K +32.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $735K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2013 $144K +$22K +18% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-21
2012 $122K +$39K +47% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-21
2011 $83K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.